SCHEMBL7567734

SCHEMBL7567734

NC=CCc1c[nH]c(-c2ccccc2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 2/20 0.35
MTOR P42345 1/20 0.33
ADK P55263 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CXCR2 P25025 1/20 0.33
DCUN1D1 Q96GG9 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
ALPL P05186 1/20 0.32
HPGD P15428 3/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11049665 0.84 MTOR (0.33) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL729737 0.80 HPGD (0.42) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL6596072 0.78 KMT2A (0.40) KMT2AMEN1ALDH1A1KDM4ECYP1A2
Hydrochloric Acid SCHEMBL7340468 0.76 KMT2A (0.39) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL672597 0.75 NOTUM (0.42) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL2780530 0.75 POLB (0.41) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL1436268 0.75 LOXL2 (0.40) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL27641126 0.75 ALPL (0.41) KMT2AKDM4ECYP1A2MTORADK
SCHEMBL30670275 0.74 MTOR (0.38) KMT2AMEN1ALDH1A1KDM4ECYP1A2
SCHEMBL2092717 0.74 MTOR (0.38) KMT2AMEN1ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6002005-A Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands NEUROGEN CORPORATION (US) 1999-12-14 US disclosed
US-5760234-A THERAPY FOR NERVOUS SYSTEM DISORDERS NEUROGEN CORPORATION (US) 1998-06-02 US disclosed
US-5750700-A COMPOUNDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS SCHIZOPHRENIA, NEUROLEPTIC AGENTS FOR BINDING TO DOPAMINE RECEPTORS NEUROGEN CORPORATION (US) 1998-05-12 US disclosed
WO-1996016057-A1 CERTAIN 1-SUBSTITUTED AMINOMETHYL IMIDAZOLE AND PYRROLE DERIVATIVES; NOVEL DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1996-05-30 WO disclosed
US-5478934-A Treating central nervous system disorders NEUROGEN CORPORATION 1995-12-26 US disclosed